{"id":9086,"date":"2013-09-25T01:24:15","date_gmt":"2013-09-25T05:24:15","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=9086"},"modified":"2013-09-25T08:27:15","modified_gmt":"2013-09-25T12:27:15","slug":"medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086","title":{"rendered":"Medtronic, Inc (NYSE:MDT)\u2019s super vascular stent approved by FDA"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 09\/25\/2013 (wallstreetpr) &#8211;\u00a0Medtronic, Inc. (NYSE: MDT) announced that the United States FDA has approved the Complete SE vascular stent that will be used in lower-extremities. This will specifically be used in the superficial femoral-artery and the proximal popliteal-artery. Both these arteries supply blood to the upper legs.<\/p>\n<p style=\"text-align: justify;\"><strong>Previous approvals<\/strong><\/p>\n<p style=\"text-align: justify;\">Originally, this same device from Medtronic, Inc (NYSE:MDT) had received FDA approval for use in iliac arteries. These arteries supply blood to the pelvic area. This device also has the CE-mark for iliac, PPA and SFA indications. The approval from the Food Drug Administration for the PPA and SFa was supported by results from the Complete SE-SFA study.<\/p>\n<p style=\"text-align: justify;\">This was an independently-adjudicated single arm, multi-center trial with 196 patient enrolments across 28 sites in Europe and the U.S. this study proved a clinically driven target-lesion revascularization rate of 8.4% at 12 months. This is amongst the best-performances in clinical-trials of similar self-expanding peripheral-stents used in the treatment of SFA\/PPA lesions.<\/p>\n<p style=\"text-align: justify;\"><strong>Other reports<\/strong><\/p>\n<p style=\"text-align: justify;\">In addition, there were none in-hospital MAE\u2019samong study patients, and the total MAE-rate at 12-months was only 11.0percent. The Kaplan-Meier estimate for primary-patency at 360 days stood at 90.9%; at the point of last duplex-ultrasound assessment, at 553 days, the primary-patency stood at 72.5%. There were no stent fractures in 12 months.<\/p>\n<p style=\"text-align: justify;\"><strong>Tuesday\u2019s trading<\/strong><\/p>\n<p style=\"text-align: justify;\">In Tuesday\u2019s trading session, Medtronic, Inc (NYSE:MDT) stock dropped by 0.61%. The shares had an opening price of $53.85 which climbed to an intraday high of $53.87 and dropped to a close of $53.43. Approximately 2.85 million shares were traded on Tuesday while an average volume of 4.53 million shares were traded over 30 days. The 52-week low of the shares was $40.28 and the 52-week high was $55.98. Medtronic, Inc (NYSE:MDT) has a market cap of $53.29 billion.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 09\/25\/2013 (wallstreetpr) &#8211;\u00a0Medtronic, Inc. (NYSE: MDT) announced that the United States FDA has approved the Complete SE vascular stent that will be used [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":9087,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236],"tags":[3022,3021,1022],"stock_ticker":[],"class_list":["post-9086","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-medtronic-inc","tag-medtronic-inc-nysemdt","tag-nysemdt","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medtronic, Inc (NYSE:MDT)\u2019s super vascular stent approved by FDA - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medtronic, Inc (NYSE:MDT)\u2019s super vascular stent approved by FDA - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 09\/25\/2013 (wallstreetpr) &#8211;\u00a0Medtronic, Inc. (NYSE: MDT) announced that the United States FDA has approved the Complete SE vascular stent that will be used [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-09-25T05:24:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2013-09-25T12:27:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/09\/medtronic2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Medtronic, Inc (NYSE:MDT)\u2019s super vascular stent approved by FDA\",\"datePublished\":\"2013-09-25T05:24:15+00:00\",\"dateModified\":\"2013-09-25T12:27:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086\"},\"wordCount\":296,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/09\/medtronic2.jpg\",\"keywords\":[\"Medtronic Inc\",\"Medtronic Inc (NYSE:MDT)\",\"NYSE:MDT\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086\",\"name\":\"Medtronic, Inc (NYSE:MDT)\u2019s super vascular stent approved by FDA - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/09\/medtronic2.jpg\",\"datePublished\":\"2013-09-25T05:24:15+00:00\",\"dateModified\":\"2013-09-25T12:27:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/09\/medtronic2.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/09\/medtronic2.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medtronic, Inc (NYSE:MDT)\u2019s super vascular stent approved by FDA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medtronic, Inc (NYSE:MDT)\u2019s super vascular stent approved by FDA - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086","og_locale":"en_US","og_type":"article","og_title":"Medtronic, Inc (NYSE:MDT)\u2019s super vascular stent approved by FDA - Wall Street PR","og_description":"Boston, MA 09\/25\/2013 (wallstreetpr) &#8211;\u00a0Medtronic, Inc. (NYSE: MDT) announced that the United States FDA has approved the Complete SE vascular stent that will be used [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-09-25T05:24:15+00:00","article_modified_time":"2013-09-25T12:27:15+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/09\/medtronic2.jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Medtronic, Inc (NYSE:MDT)\u2019s super vascular stent approved by FDA","datePublished":"2013-09-25T05:24:15+00:00","dateModified":"2013-09-25T12:27:15+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086"},"wordCount":296,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/09\/medtronic2.jpg","keywords":["Medtronic Inc","Medtronic Inc (NYSE:MDT)","NYSE:MDT"],"articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086","url":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086","name":"Medtronic, Inc (NYSE:MDT)\u2019s super vascular stent approved by FDA - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/09\/medtronic2.jpg","datePublished":"2013-09-25T05:24:15+00:00","dateModified":"2013-09-25T12:27:15+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/09\/medtronic2.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/09\/medtronic2.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdts-super-vascular-stent-approved-by-fda-9086#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Medtronic, Inc (NYSE:MDT)\u2019s super vascular stent approved by FDA"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/9086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=9086"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/9086\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/9087"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=9086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=9086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=9086"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=9086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}